XML 22 R7.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Cash flows from operating activities:    
Net income $ 32,890 $ 4,894
Adjustments to reconcile income to net cash provided by operating activities:    
Depreciation and amortization 43,053 39,793
Interest expense related to amortization of debt issue costs and debt discount 1,745 5,611
Stock-based compensation 2,337 2,069
Deferred income taxes 17,629 954
Tax benefit from exercise of stock appreciation rights and vesting of restricted stock (332) 0
Net loss (gain) on disposition of property, plant and equipment (1,631) 95
Loss on sale of discontinued operations, net of income taxes 3,072 219
Net loss of unconsolidated joint ventures 36 247
Decrease in trade receivables 4,579 506
Increase in inventories (1,879) (8,927)
Decrease in accounts payable and accrued liabilities (18,062) (29,479)
Other changes in operating assets and liabilities, net (4,030) (10,788)
Net cash provided by (used in) operating activities 79,407 5,194
Cash flows from investing activities:    
Business acquisitions, net of cash acquired (106,924) (1,200)
Investments in unconsolidated joint ventures 0 (125)
Purchase of property, plant and equipment (31,419) (26,524)
Proceeds from disposition of property, plant and equipment 8,795 716
Net decrease (increase) in long-term receivables and deposits (200) 3,847
Net change in other assets 1,869 (423)
Net cash used in investing activities (127,879) (23,709)
Cash flows from financing activities:    
Net proceeds from issuance of long-term debt 0 414,675
Payments on long-term debt (6,937) (448,736)
Dividends paid to non-controlling interest in consolidated subsidiary (735) (1,184)
Employee stock purchases 718 633
Tax benefit from exercise of stock appreciation rights and vesting of restricted stock 332 0
Net cash provided by (used in) financing activities (6,622) (34,612)
Net increase (decrease) in cash and cash equivalents (55,094) (53,127)
Cash and cash equivalents, beginning of period 142,597 152,542
Cash and cash equivalents, end of period $ 87,503 $ 99,415